• A breath of unique innovation

    Pioneering inhalation products and extensive know-how in drug formulation

    Get to know us!
  • A formulation to match the device

    The right chemistry in the right inhaler takes you to the market faster

    Take me there!
  • Capitalize on a pool of knowledge

    Get from bench to bedside – faster and at lower risk

    Discover how
  • For those who need it the most

    ICOone™ – inhale vaccine instead of injecting. Safe method that eliminates all cold-chain storage.

    Learn how
  • A breath of unique innovation »
  • A formulation to match the device »
  • Capitalize on a pool of knowledge »
  • For those who need it the most »



    Analys från Penser access: Iconovo - Stor potential vid rätt samarbetspartner. Läs mera här... Read more
  • Video interview: Iconovo’s CEO presented the company at the LSX World Congress

    Last week it was once again time for the big investor and partnering meeting focused on life science, the LSX World Cong... Read more
  • Market analys of Iconovo – Healthcare Direkt (only in swedish)

    Market analys of Iconovo by Siri Ladow, Analyst, Head of Commissoned Research Danske Bank, Sweden. Healthcare Direkt.... Read more
  • Orest Lastow change role to CTO and Johan Wäborg hired as new CEO of Iconovo AB

    Dr Orest Lastow will take on the role of CTO of Iconovo while Johan Wäborg is hired as the new CEO of Iconovo entering ... Read more
  • Iconovo aims for more innovations in inhalation

    Looking back on Iconovo’s 2019, the company’s investment in the new inhalation platform ICOpre and the accompanying ... Read more
  • Spray inhalers – a major climate change culprit according to a new study

    Compared to dry powder inhalers, spray inhalers are a significant climate change culprit. Furthermore, many patients wo... Read more
  • Directed share issue of 60 million SEK to finance Iconovo’s new inhalation platform

    A few weeks ago, Lund-based Iconovo gave a sign of their growing confidence when they announced the biggest investment i... Read more
  • Iconovo AB carries out a directed share issue and raises SEK 60 million before issue costs

    The Board of Directors of Iconovo AB ("Iconovo" or the “Company") has utilised the authorisation received at the AGM o... Read more
  • PRESS RELEASE, 19 November 2019

    Granted ICOres patent in Japan The Japan Patent Office has granted a patent regarding Iconovo’s dry powder inhaler, I... Read more
  • Iconovo met innovation companies at BIO-Europe

    At last week’s BIO-Europe conference, BioStock caught Iconovo’s Roger Lassing, VP of Business Development, between a... Read more
Older news

A unique platform of inhalation devices

Iconovo offers a full range of innovative, ready-to-use inhalation devices for dry powder inhalation (DPI). Our solution consists of a combination of inhaler and the exactly right formulation to match the device and the drug to be delivered. Each solution is based on our proprietary platform but will be customized and adapted to your unique requirements. We can also provide performance testing, full documentation and a complete supply chain. Our long and unique experience and capability in the development of inhalation devices and formulations enable you to get your product to the market in a fast and efficient way.